Gyre Therapeutics
GYRE
#5395
Rank
S$1.49 B
Marketcap
$17.43
Share price
1.03%
Change (1 day)
-44.51%
Change (1 year)

Gyre Therapeutics (GYRE) - P/B ratio

P/B ratio as of December 2024 : 11.0

According to Gyre Therapeutics's latest financial reports the company has a price-to-book ratio of 10.3445.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

Gyre Therapeutics - P/B ratio (from 2023 to 2024)

P/B ratio by year

Year P/B ratio Change
2024-12-3110.9-92.31%
2023-12-31141